It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...

Please provide your email address to receive an email when new articles are posted on . Extended prophylaxis with the oral anticoagulant dabigatran was superior in efficacy to subcutaneous enoxaparin ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — Treatment with 30 days of low-dose apixaban was no more effective than a shorter course of enoxaparin ...

However, the guidelines do have a few "exceptions," such as recommending use of higher-prophylaxis dosing in obese patients. [2] Interpreting what this "higher" dose is may be challenging. Also, one ...

June 14, 2010 (Barcelona, Spain) — Major venous thromboembolism (VTE) and VTE-related mortality occurred in 2.2% of patients receiving oral dabigatran and in 4.2% of patients receiving subcutaneous ...

Objectives: To compare the safety and effectiveness of two different thromboprophylactic protocols in the management of patients with spinal cord injury – one using heparin/warfarin and the other ...

The Department of Pharmaceuticals (DoP) has rejected a review application of Sanofi India, part of the leading multinational pharma major Sanofi, and upheld the decision of National Pharmaceutical ...

The Appraisal Committee considered evidence submitted by the manufacturer of apixaban and a review of this submission by the Evidence Review Group (ERG). The manufacturer's submission compared ...

Problems associated with contamination of heparin products continue after worldwide recalls in March in the United States, Italy, France, and Denmark. Australia, Sweden, and United Kingdom (Apr.

It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...